Oneness Biotech Co., Ltd. (TPEX:4743)
60.30
-1.00 (-1.63%)
Apr 24, 2025, 1:30 PM CST
Oneness Biotech Revenue
In the year 2024, Oneness Biotech had annual revenue of 117.93M TWD with 35.89% growth. Oneness Biotech had revenue of 31.41M in the quarter ending December 31, 2024, with 22.32% growth.
Revenue
117.93M
Revenue Growth
+35.89%
P/S Ratio
248.49
Revenue / Employee
2.74M
Employees
43
Market Cap
29.30B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 117.93M | 31.14M | 35.89% |
Dec 31, 2023 | 86.78M | -978.77M | -91.86% |
Dec 31, 2022 | 1.07B | 999.79M | 1,520.24% |
Dec 31, 2021 | 65.77M | 24.16M | 58.07% |
Dec 31, 2020 | 41.61M | 28.13M | 208.76% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Polaris Group | 107.00M |
Pegavision | 6.82B |
Lumosa Therapeutics | 39.15M |
Center Laboratories | 1.62B |